Re: PharmaCyte Biotech seems to be our main competition...
posted on
Apr 05, 2017 09:59AM
Koo....I don't consider it off topic, but from a bottom line fundamental perspective I will allow that this "award" doesn't mean much, less than a Grammy in fact. The ony impact it might have is in attracting a few eyes to RVX/RVXCF which in my books is not a bad thing. It could give the winning company fodder for a PR. What shareholder wouldn't want to see a headline like:
Resverlogix wins "Pipeline of Promise" award at Bio International Convention
But if I'm handicapping our chances of getting the most votes....I think PharmaCyte has a big edge. Being a 9 cent penny stock with almost 900 million shares outstanding, I'm assuming their shareholder base is exponentially higher than that of Resverlogix.
With that being said we're neck and neck with PharmaCyte....I just checked and we're not down by much, its 218 to 212 and I believe the votes do count right away, as soon as the verification link is clicked.